World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
71
Citations
21953
World Ranking
1361
National Ranking
690

David H. Price publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where David H. Price sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 144 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

David H. Price D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where David H. Price sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 71 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

David H. Price is affiliated with the University of Iowa in the United States. Their research spans multiple disciplines with a primary focus on biochemistry, genetics, and molecular biology, contributing extensively to the fields of molecular biology and medicine. The subfields that characterize their work include molecular biology, epidemiology, cancer research, oncology, and immunology.

Price's scientific contributions center on several key research topics. These encompass RNA modifications and cancer, genomics and chromatin dynamics, RNA research and splicing, cytomegalovirus and herpesvirus research, herpesvirus infections and treatments, cancer in relation to hypoxia and metabolism, and RNA regulation in disease contexts.

Among the scientist's recent publications are:

  • "MYC assembles and stimulates topoisomerases 1 and 2 in a 'topoisome'" (2021, Molecular Cell)
  • "Differential dependencies of human RNA polymerase II promoters on TBP, TAF1, TFIIB and XPB" (2022, Nucleic Acids Research)
  • "A unified view of the sequence and functional organization of the human RNA polymerase II promoter" (2020, Nucleic Acids Research)
  • "Human cytomegalovirus IE2 drives transcription initiation from a select subset of late infection viral promoters by host RNA polymerase II" (2020, PLoS Pathogens)
  • "DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation" (2023, eLife)

Frequent co-authors of Price's work include Juan F. Santana, Mrutyunjaya Parida, Benjamin M. Spector, Jeffery L. Meier, and Ming Li. These collaborators have contributed to multiple joint publications, highlighting a pattern of ongoing partnerships in their research efforts.

Price's work has appeared regularly in several scientific publication venues. The primary journals and repositories include Nucleic Acids Research, UNC Libraries, PLoS Pathogens, Viruses, and Molecular Cell.

In recognition of contributions to science, Price was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2013.

Best Publications

  • Controlling the Elongation Phase of Transcription with P-TEFb

    B. Matija Peterlin;David H. Price

  • P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

    David H. Price

  • Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro

    Yuerong Zhu;Tsafrira Pe’ery;Junmin Peng;Yegnanarayana Ramanathan

  • Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase *

    Nick F. Marshall;Junmin Peng;Zhi Xie;David H. Price

  • Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.

    Sheng Hao Chao;David H. Price

  • Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation

    Nick F. Marshall;David H. Price

  • P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro.

    Helena S.Y. Mancebo;Gary Lee;John Flygare;Joanne Tomassini

  • Identification of multiple cyclin subunits of human P-TEFb

    Junmin Peng;Yuerong Zhu;Jeffrey T. Milton;David H. Price

  • RNA polymerase II elongation control

    Qiang Zhou;Tiandao Li;David H. Price

  • Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.

    Sheng-Hao Chao;Koh Fujinaga;Jon E. Marion;Ran Taube

  • Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.

    Guy Van Hazel;Anthony Blackwell;James Anderson;David Price

  • Systematic Analysis of the Protein Interaction Network for the Human Transcription Machinery Reveals the Identity of the 7SK Capping Enzyme

    Célia Jeronimo;Diane Forget;Annie Bouchard;Qintong Li

  • CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1

    Bartlomiej Bartkowiak;Pengda Liu;Hemali P. Phatnani;Nicholas J. Fuda

  • Control of formation of two distinct classes of RNA polymerase II elongation complexes.

    N F Marshall;D H Price

  • SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

    Guy A. van Hazel;Volker Heinemann;Navesh K. Sharma;Michael P.N. Findlay

  • P-TEFb kinase recruitment and function at heat shock loci.

    John T. Lis;Paul Mason;J. Peng;David H. Price

  • Radioembolization of Liver Metastases From Colorectal Cancer Using Yttrium-90 Microspheres With Concomitant Systemic Oxaliplatin, Fluorouracil, and Leucovorin Chemotherapy

    Ricky A. Sharma;Guy A. Van Hazel;Bruno Morgan;David P. Berry

  • Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription

    Meisheng Zhou;Matthew A. Halanski;Michael F. Radonovich;Fatah Kashanchi

  • RNA polymerase II elongation control.

    J. Peng;M. Liu;J. Marion;Y. Zhu

  • Crystal structure of HIV-1 Tat complexed with human P-TEFb.

    Tahir H. Tahirov;Nigar D. Babayeva;Katayoun Varzavand;Jeffrey J. Cooper

Frequent Co-Authors

Junmin Peng
Junmin Peng St. Jude Children's Research Hospital
B. Matija Peterlin
B. Matija Peterlin University of California, San Francisco
Arno L. Greenleaf
Arno L. Greenleaf Duke University
Yi Zhou
Yi Zhou Harvard University
Leonard I. Zon
Leonard I. Zon Harvard University
Olivier Bensaude
Olivier Bensaude École Normale Supérieure
Fatah Kashanchi
Fatah Kashanchi George Mason University
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Michael W. Gray
Michael W. Gray Dalhousie University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology can open doors to a variety of science and healthcare careers. If you are considering related fields or want flexible options, online degrees offer both affordability and accessibility. For those interested in information management, the cheapest library science degree online programs can be a great option, providing cost-effective pathways into library and data science.

If your interests lean toward healthcare and communication, consider asha accredited slpa programs. These programs lead to roles as Speech-Language Pathology Assistants and offer credibility with professional standards. For students with non-SLP backgrounds who wish to transition into this sector, an slp bridge program online allows you to meet prerequisites for graduate study efficiently.

Those looking to shift into the medical field can also consider online accelerated nursing programs for non nurses. These degrees are designed for career changers, helping you earn a BSN in less time and start a rewarding career in nursing.

Best Scientists Citing David H. Price

Trending Scientists

Recently Published Articles